Author: lisa

  • T-Heart appoints Stephane Delaloye as acting Chief Technical Officer

    Paris, France, 4 July 2022 – T-Heart, a privately-owned medtech company developing a truly novel and differentiated transcatheter tricuspid prosthetic heart valve that is specifically designed for tricuspid regurgitation, today announced it has appointed Stephane Delaloye as Acting Chief Technical Officer. In this role, he will be responsible for coordinating T-Heart’s R&D activities and driving an efficient…

  • T-Heart raises €8m in series A financing to cover the development of the tricuspid transcatheter heart valve

    Paris, France, July 18, 2019 – T-Heart, a privately-owned medtech company developing a truly novel and differentiated transcatheter tricuspid prosthetic heart valve that is specifically designed for tricuspid heart valve regurgitation, today announced it has closed a Series A round of financing, raising €8 million from iBionext. The company was created in December 2018 within the company…